Promentis Pharmaceuticals, Inc. — Form D/A

Promentis Pharmaceuticals, Inc. of MILWAUKEE, WI, a company, filed a Form D amendment with the SEC on 2009-08-31. The offering totals $2.5M, of which $1.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
David A Baker, PhDDirectorMilwaukee, WI
Ed BarthellDirectorMequon, WI
Klaus VeitingerDirectorChanhassen, MN
Klaus VeitingerExecutive OfficerChanhassen, MN
Stacey SeltzerDirectorSan Diego, CA
Chad BeyerExecutive OfficerMilwaukee, WI
Steve SquintoDirectorMilwaukee, WI
Thomas BeckDirectorMilwaukee, WI
Patrick Schwarz-SchuetteDirectorMilwaukee, WI
Daniel LawtonDirectorMilwaukee, WI
Daniel LawtonExecutive OfficerMilwaukee, WI
Tom BeckDirectorMilwaukee, WI
Tom BeckExecutive OfficerMilwaukee, WI
Klaus E Veitinger, MD, PhDDirectorMilwaukee, WI
David E Baker, PhDDirectorMilwaukee, WI
Ed E Barthell, MDDirectorMequon, WI
Chad E Beyer, PhDDirectorMilwaukee, WI
Chad E Beyer, PhDExecutive OfficerMilwaukee, WI
Daniel E LawtonDirectorMilwaukee, WI
Patrick E Schwarz-SchuetteDirectorDusseldorf, 2M
Virinder E Nohria, PhDDirectorMilwaukee, WI
Ed A Barthell, MDDirectorMequon, WI
Virinder A Nohria, PhDDirectorMilwaukee, WI
Thomas A ShannonDirectorSaukville, WI
Klaus A Veitinger, MD, PhDDirectorMilwaukee, WI

Other filings by this issuer (6)

FiledFormOfferingSold
2019-12-27D$6.0M$2.5M
2017-09-25D$17.6M$17.6M
2016-10-05D$8.8M$8.8M
2014-01-15D$2.9M$820K
2013-04-01D$750K$750K
2009-08-28D$2.5M$1.7M

More